133 related articles for article (PubMed ID: 20388772)
1. Immunohistochemical expression of BRCA1 and lethal prostate cancer.
Fiorentino M; Judson G; Penney K; Flavin R; Stark J; Fiore C; Fall K; Martin N; Ma J; Sinnott J; Giovannucci E; Stampfer M; Sesso HD; Kantoff PW; Finn S; Loda M; Mucci L
Cancer Res; 2010 Apr; 70(8):3136-9. PubMed ID: 20388772
[TBL] [Abstract][Full Text] [Related]
2. Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer.
Stopsack KH; Gerke T; Zareba P; Pettersson A; Chowdhury D; Ebot EM; Flavin R; Finn S; Kantoff PW; Stampfer MJ; Loda M; Fiorentino M; Mucci LA
Carcinogenesis; 2020 Jul; 41(7):904-908. PubMed ID: 32556091
[TBL] [Abstract][Full Text] [Related]
3. Common variation in BRCA1 may have a role in progression to lethal prostate cancer after radiation treatment.
Sanchez A; Schoenfeld JD; Nguyen PL; Fiorentino M; Chowdhury D; Stampfer MJ; Sesso HD; Giovannucci E; Mucci LA; Shui IM
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):197-201. PubMed ID: 26926928
[TBL] [Abstract][Full Text] [Related]
4. Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
Omari A; Nastały P; Stoupiec S; Bałabas A; Dąbrowska M; Bielińska B; Huss S; Pantel K; Semjonow A; Eltze E; Brandt B; Bednarz-Knoll N
Int J Cancer; 2019 Feb; 144(3):607-614. PubMed ID: 30265376
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.
Schayek H; Haugk K; Sun S; True LD; Plymate SR; Werner H
Clin Cancer Res; 2009 Mar; 15(5):1558-65. PubMed ID: 19223505
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
8. Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells.
Vardi A; Bosviel R; Rabiau N; Adjakly M; Satih S; Dechelotte P; Boiteux JP; Fontana L; Bignon YJ; Guy L; Bernard-Gallon DJ
In Vivo; 2010; 24(4):393-400. PubMed ID: 20668305
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype.
Gorodetska I; Lukiyanchuk V; Peitzsch C; Kozeretska I; Dubrovska A
Int J Cancer; 2019 Dec; 145(11):2974-2985. PubMed ID: 30968962
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of the mutated BRCA1 mRNA and p53 mRNA and its association in Chinese prostate cancer.
Ding GF; Xu YF; Yang ZS; Ding YL; Fang HF; Zhao HP
Urol Oncol; 2011; 29(2):145-9. PubMed ID: 19269198
[TBL] [Abstract][Full Text] [Related]
12. BRCA1, Ki67, and β-Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma.
Sallum LF; Andrade L; Bastos Eloy da Costa L; Ramalho S; Ferracini AC; Natal RA; Brito ABC; Sarian LO; Derchain S
Int J Gynecol Cancer; 2018 Mar; 28(3):437-447. PubMed ID: 29465506
[TBL] [Abstract][Full Text] [Related]
13. Mutations in BRCA2 and taxane resistance in prostate cancer.
Nientiedt C; Heller M; Endris V; Volckmar AL; Zschäbitz S; Tapia-Laliena MA; Duensing A; Jäger D; Schirmacher P; Sültmann H; Stenzinger A; Hohenfellner M; Grüllich C; Duensing S
Sci Rep; 2017 Jul; 7(1):4574. PubMed ID: 28676659
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
15. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.
Revelos K; Petraki C; Gregorakis A; Scorilas A; Papanastasiou P; Tenta R; Koutsilieris M
In Vivo; 2005; 19(5):911-20. PubMed ID: 16097446
[TBL] [Abstract][Full Text] [Related]
16. Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland.
Wang M; Yu B; Westerlind K; Strange R; Khan G; Patil D; Boeneman K; Hilakivi-Clarke L
Breast Cancer Res Treat; 2009 May; 115(1):213-20. PubMed ID: 18516675
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and prostate cancer.
Rosen EM; Fan S; Goldberg ID
Cancer Invest; 2001; 19(4):396-412. PubMed ID: 11405179
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins.
Fan S; Wang JA; Yuan RQ; Ma YX; Meng Q; Erdos MR; Brody LC; Goldberg ID; Rosen EM
Oncogene; 1998 Jun; 16(23):3069-82. PubMed ID: 9662340
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 mutations and prostate cancer in Poland.
Cybulski C; Górski B; Gronwald J; Huzarski T; Byrski T; Debniak T; Jakubowska A; Wokołorczyk D; Gliniewicz B; Sikorski A; Stawicka M; Godlewski D; Kwias Z; Antczak A; Krajka K; Lauer W; Sosnowski M; Sikorska-Radek P; Bar K; Klijer R; Romuald Z; Małkiewicz B; Borkowski A; Borkowski T; Szwiec M; Posmyk M; Narod SA; Lubiński J
Eur J Cancer Prev; 2008 Feb; 17(1):62-6. PubMed ID: 18090912
[TBL] [Abstract][Full Text] [Related]
20. Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival.
Alvarez C; Aravena A; Tapia T; Rozenblum E; Solís L; Corvalán A; Camus M; Alvarez M; Munroe D; Maass A; Carvallo P
BMC Cancer; 2016 Mar; 16():219. PubMed ID: 26979459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
